Amgen Patent Ruling's Impact Extends Beyond Life Sciences
In Amgen Inc. v. Sanofi, the U.S. Supreme Court in May further clarified the patent enablement requirement.[1] At issue in the case were Amgen's patents that claimed a wide class of...To view the full article, register now.
Already a subscriber? Click here to view full article